Adverum Biotechnologies Funding & Investors
Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
adverum.comTotal Amount Raised: $687,372,608
Adverum Biotechnologies Funding Rounds
Post Ipo Equity
$130,500,000
Post Ipo Equity
$9,999,995
Series B
$55,000,000
Series B Investors
Redmile GroupVenrockDeerfield ManagementAdage Capital ManagementSabby CapitalRock Springs CapitalPost Ipo Equity
$69,000,000
Post Ipo Equity
$50,000,000
Series Unknown
$5,653,890
Post Ipo Equity
$217,000,000
Post Ipo Equity
$150,218,750
Funding info provided by Diffbot.